Blue Jet Healthcare Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Blue Jet Healthcare Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Debt Due Cover Ratio: Debt due within a year is covered 72.6 times by its yearly operating cash. Higher than 94% of Healthcare companies in India.
- Cash Locked Ratio: For every ₹100 of sales, ₹50 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹43 tied up three years earlier. More money tied up than 90% of Healthcare companies in India.
- Growth Efficiency Ratio: Sales grew 31% in 3 years; of every extra ₹100 of sales, ₹39 became extra profit. Higher than 87% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹87Over the last 3 years, every ₹100 of reported profit came with ₹87 of operating cash.
Lower than 66% of Healthcare companies in India.
Self-Funding Ratio
1.3×Over the last 3 years its own operating cash covered its investment spending (capex) 1.3 times.
Lower than 52% of Healthcare companies in India.
Cash Locked Ratio
₹50For every ₹100 of sales, ₹50 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹43 tied up three years earlier.
More money tied up than 90% of Healthcare companies in India.
Growth quality
Steadiness Ratio
1/3 · 2/3Sales grew in 1 of the last 3 years; profit grew in 2 of 3.
Less steady than 84% of Healthcare companies in India.
Growth Efficiency Ratio
₹39Sales grew 31% in 3 years; of every extra ₹100 of sales, ₹39 became extra profit.
Higher than 87% of Healthcare companies in India.
Asset Productivity Ratio
+31% / +90%In 3 years sales changed by +31% while total assets changed by +90%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
72.6×Debt due within a year is covered 72.6 times by its yearly operating cash.
Higher than 94% of Healthcare companies in India.
Cash Cushion Ratio
+3%Cash, after subtracting all debt, equals 3% of its market value (net cash).
Higher than 75% of Healthcare companies in India.
Tangible Assets Ratio
100%Of every ₹100 the company owns, ₹100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 78% of Healthcare companies in India.
Tangible Net Worth Ratio
100%Of every ₹100 of net worth, ₹100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 80% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Blue Jet Healthcare Limited owes ₹0.17 for every ₹1 it owns. Net profit fell 19% in the year to Mar 2026, and grew 16% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
36.0Investors pay ₹36.0 for every ₹1 of Blue Jet Healthcare Limited's yearly profit, lower than 51% of Healthcare companies in India.
P/B ratio
6.22The share price is 6.22 times Blue Jet Healthcare Limited's book value per share, higher than 69% of Healthcare companies in India.
Market cap
₹8,460 CrThe total market value of all of Blue Jet Healthcare Limited's shares at today's price (share price × number of shares), larger than 61% of Healthcare companies in India. PosiCap size class: Mini Cap.
Net worth (book value)
₹1,360 CrWhat Blue Jet Healthcare Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹78.40Net worth divided by the number of shares. The share price of ₹487.70 is 6.2 times this, which is the P/B above.
Return on equity (ROE)
17.3%Blue Jet Healthcare Limited earned 17.3% on its shareholders' money over the last year, higher than 69% of Healthcare companies in India.
Owes vs Owns
0.17×Blue Jet Healthcare Limited owes ₹0.17 for every ₹1 it owns (low), lower than 87% of Healthcare companies in India.
Dividend yield
0.23%Blue Jet Healthcare Limited pays 0.23% of its share price as dividends a year, lower than 67% of dividend-paying Healthcare companies in India.
Revenue growth
-8%Revenue fell 8% in the year to Mar 2026, and grew 9% a year on average over 3 years.
Profit growth
-19%Net profit fell 19% in the year to Mar 2026, and grew 16% a year on average over 3 years.
Profit margin
26.2%Blue Jet Healthcare Limited keeps ₹26 of every ₹100 of revenue as net profit.
Cash quality
1.3×Cash from Blue Jet Healthcare Limited's business was 1.3× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
43.3×Blue Jet Healthcare Limited's operating profit covered its interest costs 43.3 times in the year to Mar 2026.
Cash vs debt
Net cashBlue Jet Healthcare Limited held ₹281 Cr more cash than debt (net cash) at Mar 2026.
Questions
What is Blue Jet Healthcare Limited's P/E ratio?
Investors pay ₹36.0 for every ₹1 of Blue Jet Healthcare Limited's yearly profit, lower than 51% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Blue Jet Healthcare Limited: ₹8,460 Cr ÷ ₹1,360 Cr (31 Mar 2026) = 6.2.
What is Blue Jet Healthcare Limited's return on equity?
Blue Jet Healthcare Limited earned 17.3% on its shareholders' money over the last year, higher than 69% of Healthcare companies in India.
How much does Blue Jet Healthcare Limited owe compared with what it owns?
Blue Jet Healthcare Limited owes ₹0.17 for every ₹1 it owns (low), lower than 87% of Healthcare companies in India.
Does Blue Jet Healthcare Limited pay a dividend?
Yes. Blue Jet Healthcare Limited pays 0.23% of its share price as dividends a year, lower than 67% of dividend-paying Healthcare companies in India.
Is Blue Jet Healthcare Limited's revenue growing?
Revenue fell 8% in the year to Mar 2026, and grew 9% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.